Silencing H19 reduced inflammatory cytokines (IL-8, IL-1β, and IL-6), while H19 overexpression reversed this effect, indicating that H19 enhances inflammation through the TAK1 pathway in RA (112). Here, CXCL8 is linked to rheumatoid arthritis.